Table 4. NS5A L31/Y93 RASs in mouse inoculated with full-genome HCV RNA followed by 4 weeks of LDV monotherapy.
| L31-Y93 | L31V-Y93 | L31-Y93H | L31V-Y93H | |
|---|---|---|---|---|
| week 6 | 99.5% | — | — | — |
| (before treatment) | ||||
| week 14 | 0.3% | — | 99.5% | — |
| (LDV post 4 w) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.